Clinical trial ICON
A randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Oui |
| Sponsor | Oslo University Hospital |
| EudraCT Identifier | 2017-000220-10 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03409198 |
| Inclusion criteria | ER+/HER2-. Metastatic |
| Last update |